Skip to content
For investors

Does this claim survive?

You are about to sign a memo whose technical thesis rests on someone else’s press release. The risk is not missing the upside. The risk is that the claim erodes six months after the wire clears, and the reasoning behind your decision was never written down anywhere you can point to.

Get in touch →See a real one: V-0012 →

What diligence looks like today

What diligence looks like today

  • A scientific advisor bills by the hour and leaves no artifact you can file.
  • The vendor’s paper reports the baseline the vendor chose.
  • A professor you trust gives you an opinion, not a dated record.
  • None of the three survives a question from your LP eighteen months later.
What we do instead

What we do instead

We take one published claim and place it on the evidence scale: what was measured, against which classical method, at what budget, and who has challenged it since. You get the record and the date, not an opinion.

What you get

A decision page with the claim’s evidence level, its survival status, every challenge on record with its date, and what would have to happen for it to move up a level. Sealed, hash-anchored, with a citable ID. Public or private, your call.

Price

Price

Claim Screening — US$4,500 · 5 business days.

Portfolio Scan — five screenings plus one full diligence report. Separately that is 5 × US$4,500 + US$28,000 = US$50,500; together, US$42,500.

All pricing → · What else you could use →

From the ledger, for you

From the ledger, for you

Sixteen advantage claims tracked since 2009. Three still standing. Six eroded under later work. The fastest challenge on record landed two days before the claim was published.

Open the survival registry →

We do not bill the vendors we judge. That is the whole product.